$29.700
+2.340 (+7.88%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MAZE Prediction & Forecast by Similar Chart Analysis
Alphio's MAZE stock price prediction model matches the current Maze Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $29.84 (+0.46%). The 1-week path is $29.88 (+0.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Maze Therapeutics Inc Stock?
Maze Therapeutics is a good buy right now, as it is currently priced at $27.53, with a forward P/E of 8.53, indicating potential undervaluation. The RSI is at 61.38, suggesting bullish momentum, and analysts project significant upside with targets of $50 and $64. However, the main risk is the recent insider stock sale by the Chief Medical Officer, which may indicate concerns about the company's future prospects.
MAZE stock price ended at $29.70 on Monday, after rising +7.88%
Maze Therapeutics Inc (MAZE) last closed at $29.7, gaining +7.88%. These facts feed the 1-day and 1-week MAZE price prediction above.
Forecast Drivers
Maze Therapeutics Inc (MAZE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MAZE, ranked by similarity.
Seasonality analysis for MAZE
Historically the probability of a positive October return for MAZE is 63.89%. November offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MAZE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $19.00 | $21.47 | $24.22 | -27.71% |
| Nov 2026 | $18.37 | $19.16 | $20.07 | -35.48% |
| Dec 2026 | $16.57 | $18.70 | $21.54 | -37.05% |
In 2026, Maze Therapeutics Inc (MAZE) is projected to range from $16.57 to $24.22.
Maze Therapeutics Inc 2026 monthly forecast
In Oct 2026, Maze Therapeutics Inc is projected to average $21.47, with a low of $19.00 and high of $24.22.
In Nov 2026, Maze Therapeutics Inc is projected to average $19.16, with a low of $18.37 and high of $20.07.
In Dec 2026, Maze Therapeutics Inc is projected to average $18.70, with a low of $16.57 and high of $21.54.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.